Compumedics Statistics

Total Valuation

Compumedics has a market cap or net worth of AUD 55.69 million. The enterprise value is 64.29 million.

Market Cap	55.69M
Enterprise Value	64.29M

Important Dates

The next estimated earnings date is Thursday, August 28, 2025.

Earnings Date	Aug 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Compumedics has 192.04 million shares outstanding. The number of shares has increased by 24.92% in one year.

Current Share Class	192.04M
Shares Outstanding	192.04M
Shares Change (YoY)	+24.92%
Shares Change (QoQ)	-12.97%
Owned by Insiders (%)	56.26%
Owned by Institutions (%)	3.07%
Float	61.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	29.00
PS Ratio	1.18
PB Ratio	2.60
P/TBV Ratio	2.60
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 77.55, with an EV/FCF ratio of -40.95.

EV / Earnings	-40.35
EV / Sales	1.36
EV / EBITDA	77.55
EV / EBIT	n/a
EV / FCF	-40.95

Financial Position

The company has a current ratio of 1.21, with a Debt / Equity ratio of 0.59.

Current Ratio	1.21
Quick Ratio	0.63
Debt / Equity	0.59
Debt / EBITDA	15.15
Debt / FCF	-8.00
Interest Coverage	-0.55

Financial Efficiency

Return on equity (ROE) is -8.08% and return on invested capital (ROIC) is -0.97%.

Return on Equity (ROE)	-8.08%
Return on Assets (ROA)	-0.67%
Return on Invested Capital (ROIC)	-0.97%
Return on Capital Employed (ROCE)	-2.16%
Revenue Per Employee	305,639
Profits Per Employee	-10,277
Employee Count	155
Asset Turnover	1.07
Inventory Turnover	1.67

Taxes

In the past 12 months, Compumedics has paid 292,000 in taxes.

Income Tax	292,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.69% in the last 52 weeks. The beta is 0.50, so Compumedics's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	-1.69%
50-Day Moving Average	0.28
200-Day Moving Average	0.28
Relative Strength Index (RSI)	59.38
Average Volume (20 Days)	60,976

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Compumedics had revenue of AUD 47.37 million and -1.59 million in losses. Loss per share was -0.01.

Revenue	47.37M
Gross Profit	24.92M
Operating Income	-477,000
Pretax Income	-1.30M
Net Income	-1.59M
EBITDA	15,000
EBIT	-477,000
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 3.96 million in cash and 12.56 million in debt, giving a net cash position of -8.59 million or -0.04 per share.

Cash & Cash Equivalents	3.96M
Total Debt	12.56M
Net Cash	-8.59M
Net Cash Per Share	-0.04
Equity (Book Value)	21.39M
Book Value Per Share	0.11
Working Capital	5.27M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.30 million and capital expenditures -273,000, giving a free cash flow of -1.57 million.

Operating Cash Flow	-1.30M
Capital Expenditures	-273,000
Free Cash Flow	-1.57M
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross margin is 52.61%, with operating and profit margins of -1.01% and -3.36%.

Gross Margin	52.61%
Operating Margin	-1.01%
Pretax Margin	-2.75%
Profit Margin	-3.36%
EBITDA Margin	0.03%
EBIT Margin	-1.01%
FCF Margin	n/a

Dividends & Yields

Compumedics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.92%
Shareholder Yield	n/a
Earnings Yield	-2.86%
FCF Yield	-2.82%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Compumedics has an Altman Z-Score of 1.78 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.78
Piotroski F-Score	1